Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$7.31 - $11.18 $2.88 Million - $4.4 Million
-393,836 Reduced 41.26%
560,580 $4.23 Million
Q4 2022

Feb 14, 2023

BUY
$9.48 - $14.52 $1.38 Million - $2.12 Million
145,760 Added 18.02%
954,416 $9.67 Million
Q3 2022

Nov 14, 2022

BUY
$9.2 - $13.68 $1.14 Million - $1.7 Million
124,345 Added 18.17%
808,656 $8 Million
Q2 2022

Aug 15, 2022

BUY
$5.72 - $10.65 $3.91 Million - $7.29 Million
684,311 New
684,311 $7.29 Million

Others Institutions Holding ABCL

About AbCellera Biologics Inc.


  • Ticker ABCL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 285,139,008
  • Market Cap $841M
  • Description
  • AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...
More about ABCL
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.